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Abstract
: Gene expression in human mitochondria has variousBackground
idiosyncratic features. One of these was recently revealed as the
unprecedented recruitment of a mitochondrially-encoded tRNA as a structural
component of the large mitoribosomal subunit. In porcine particles this is
mt-tRNA  whilst in humans it is mt-tRNA . We have previously shown that
when a mutation in mt-tRNA  causes very low steady state levels, there is
preferential recruitment of mt-tRNA . We have investigated whether this
altered mitoribosome affects intra-organellar protein synthesis.
: By using mitoribosomal profiling we have revealed aspects ofMethods
mitoribosome behaviour with its template mt-mRNA under both normal
conditions as well as those where the mitoribosome has incorporated mt-tRNA
.
: Analysis of the mitoribosome residency on transcripts under controlResults
conditions reveals that although mitochondria employ only 22 mt-tRNAs for
protein synthesis, the use of non-canonical wobble base pairs at codon position
3 does not cause any measurable difference in mitoribosome occupancy
irrespective of the codon. Comparison of the profile of aberrant mt-tRNA
containing mitoribosomes with those of controls that integrate mt-tRNA
revealed that the impaired translation seen in the latter was not due to stalling
on triplets encoding either of these amino acids. The alterations in
mitoribosome interactions with start codons was not directly attributable to the
either the use of non-cognate initiation codons or the presence or absence of 5’
leader sequences, except in the two bicistronic RNA units,   and RNA7 RNA14
where the initiation sites are internal.
: These data report the power of mitoribosomal profiling in helpingConclusions
to understand the subtleties of mammalian mitochondrial protein synthesis.
Analysis of profiles from the mutant mt-tRNA  cell line suggest that despite
mt-tRNA  being preferred in the porcine mitoribosome, its integration into the
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 mt-tRNA  being preferred in the porcine mitoribosome, its integration into the
human counterpart results in a suboptimal structure that modifies its interaction
with mt-mRNAs.
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            Amendments from Version 1
We apologise that the relevance of the blue crosses was not 
included in the figure legend for Figure 1A, although it was in 
the main text “where there is a statistically significant difference 
(marked by a cross below the codon)”. We have added ‘blue’ 
at this point and also added text to the legend for Figure 1 to 
improve understanding.
Unfortunately, the original Figure 1 had the q values in panels A and 
B, somehow panel 1A has the p-value data. We have reverted this 
to the q-value data, which indicates fewer instances of significant 
difference, so that it matches the text and methodology.
We apologise for the typo referring to panel 1C, it is MTCO2 not 
MTCO1. We have amended the text.
See referee reports
REVISED
Introduction
Understanding the process of protein synthesis and determining 
the features that govern the progression of the ribosome along 
its template RNA have been areas of interest for many years. 
A recent wave of publications to address these long standing 
questions was initiated by the technical development of ribosome 
profiling by Ingolia and colleagues1. The approach uses high 
density sequencing of ribosome-protected mRNA fragments 
to identify the positions within the transcript where there is an 
accumulation of ribosomes. There are many features that can con-
tribute to the pausing and processivity of the synthetic machinery 
as it translates its template mRNA and it is becoming apparent 
that this is not as simple as, or restricted to, the secondary 
structure of the RNA ahead of the ribosome. Pausing may also 
be regulated by the abundance of charged tRNA, the number of 
consecutive codons for the same amino acid2, the charge of the 
newly synthesised peptide, folding and secondary structure of 
the peptide fragment within the exit tunnel3,4, the influence 
of non-canonical wobble bases in codon:anticodon pairing5 or 
by chemical damage of mRNAs or their degradation such that 
they lack a stop codon. Transient accumulation of ribosomes 
can also be observed at sites of translation initiation, whilst 
ribosomes are localising to particular subcellular locations6 or 
during recruitment of chaperones or regulatory factors7.
To date, much of the evaluation of ribosomal profiles has been 
qualitative8, which has provided useful and interesting insights. 
As a result, new quantitative algorithms have been developed, 
which have improved the quantitative interpretation of the large 
data sets that are generated by the high-throughput sequencing. 
Quantitative profile evaluation allows sensitive statistical analyses 
that would not be achievable through the old style cloning and 
sequencing9–11. Ribosome profiling has been applied to a number 
of systems including Caulobacter, Plasmodium, yeast, zebrafish, 
rat and Arabidopsis as well determining changes in response to 
different physiological conditions12–18. A number of studies have 
looked at the ribosome profiles of nuclear encoded transcripts of 
mitochondrially-destined proteins, under different conditions or 
in the proximity of mitochondria compared to other subcellular 
compartments16,19–21 but there has been less interrogation of the 
ribosome profile of the human mitochondrial transcriptome22.
The first publication describing ribosomal profiling in human 
mitochondria focussed on the consequences of a mutation in 
MT-TW, the gene encoding mitochondrial tRNA tryptophan22. 
The data from that study saw an increased protection of many 
but not all triplets corresponding to tryptophan and a reduction of 
the proportion of protected RNA fragments downstream, which 
was interpreted as a change in translation rate due to the altered 
progression through the remainder of the open reading frame22. 
The scope of this elegant study restricted itself to the consequences 
of the mutated tRNA participating in protein synthesis, leaving 
many of the actual features associated with mitoribosome profiles 
unanalysed under control conditions. Mitoribosome distribution 
has also been assessed following administration of an arginine 
analogue to determine the effect of this misincorporation on 
intra-organellar protein synthesis23. These data limited the com-
parison of mitoribosome distribution to only MTCO1 transcript 
with and without treatment, and the frequency of arginine 
codons found within protected footprints compared to untreated 
controls. Since there are many ways to analyse the output, the 
data we present here, although not comprehensive, provides a 
broad analysis, under control conditions, of features relating to 
the coding triplets found within protected fragments and also 
across open reading frames.
It is now known that the mitochondrially-encoded tRNAVal is 
incorporated as a structural component of the human 
mitoribosome24–26. This unprecedented incorporation of a tRNA 
rather than a 5S rRNA is also seen in other mammalian mitori-
bosomes but appears to be restricted to either mt-tRNAPhe or 
mt-RNAVal24,27. We recently published that in human cells with a 
mutated, unstable mt-tRNAVal there is a preferential incorporation 
of mt-tRNAPhe into the mitoribosome27,28. Since this mt-tRNA 
is found in porcine and bovine mitoribosomes, it is possible 
that this substitution would generate fully functional mitoribos-
omes. Here we present data concerning mitoribosome pausing 
not only from control cells but also from our extended inves-
tigations determining whether substitution of mt-tRNAVal for 
mt-tRNAPhe as the structural mt-tRNA incorporated into mt-LSU27 
has an effect on these profiles.
Methods
Cell culture
Human 143B.206 Rho+ cells and cybrid derivatives27 were cultured 
(37°C, humidified 5% CO2) in DMEM (Sigma) supplemented 
with 10% (v/v) foetal calf serum, 1x non-essential amino acids, 
50µg/mL uridine, and 2mM L-glutamine.
Generation and analysis of mitoribosome protected 
fragments
These were generated as described in Rooijers et al.22. Control 
ribosome profiling data are deposited in NCBI Gene Expression 
Omnibus (accession codes GSE48933). Raw data from experi-
mental samples is deposited in ebi ArrayExpress (E-MTAB-6284). 
Libraries were sequenced by Edinburgh Genomics, Genome 
Science on a high throughput Illumina HiSeq2500 platform. 
Adapter sequences were removed using cutadapt (version 1.4.2) 
and the trimmed fastq files were filtered using bowtie2 
(version 2.2.3) to remove tRNA and rRNA sequences from 
both nuclear and mitochondrial genomes as described in 22. The 
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remaining sequences were then aligned to the human mitochon-
drial reference sequence using bowtie222.
Identification of mitoribosome pausing
To facilitate direct comparison between profiles we generated 
fractional profiles. Footprint fractional profiles were generated 
by dividing footprint profiles by total number of reads per repli-
cate. A fractional abundance profile was generated by dividing 
the mtDNA abundance profile by the total number of codons 
within the coding region of mtDNA, where the total of all signals 
was equal to 1.
To identify motifs associated with mitoribosome pausing, we 
carried out multiple, one-sample, two-tailed t-tests comparing 
three replicate observations of the fractional footprint profile values 
with fractional abundance profile values at each codon using the 
t.test function in R (version 3.4.1). This procedure generated a 
list of p-values for the statistical significance of differences observed 
at each codon. In order to account for the Type I error associ-
ated with multiple testing of 64 codons, we used FDR correction 
to generate a list of corrected q-values (using the p.adjust 
function in R). We classified differences where q < 0.05 as 
significant. We repeated this procedure for the wild-type cell line 
and the mutant cell line separately.
To identify the effects of preferential integration of mt-tRNAPhe, 
we carried out multiple, two-sample, two-tailed t-tests comparing 
three replicate observations of the fractional footprint profile 
values from the wild-type cell line with three replicate observa-
tions of the fractional footprint profile values from the mutant 
cell line. As above, we first generated 64 p-values and corrected 
for multiple testing to give 64 corrected q-values, classifying 
differences where q < 0.05 as significant.
Plots of footprints covering the 5’ termini
All footprints that started from the very 5’ terminus to 5 nucle-
otides downstream of the of the start codon, were mapped to their 
nucleotide position of the mtDNA reference sequence29, irrespec-
tive of their individual lengths (x-axis represents the nucleotide 
position in the reference mtDNA). These footprints were mapped 
as blocks where the depth (y axis) of the block is proportional 
to the frequency with which that specific length of footprint, in 
that position, is found as part of the selected sequences from the 
library.
Profile clustering
We generated tRNA footprint profiles from sequencing data by 
summing up the number of reads at each codon in the coding 
region of mtDNA. We generated an mtDNA abundance profile 
by counting the number of occurrences of each codon within the 
coding region of mtDNA. Differences between tRNA footprint 
profiles for the three replicates from the wild-type strain, the 
three replicates from the mutant that preferentially integrates 
mt-tRNAPhe and the mtDNA abundance profile were examined 
by unsupervised hierarchical clustering. Differences between 
profiles i and j were defined as 1 - Pij, where Pij is the Pearson’s 
correlation coefficient between profiles i and j. Clustering was 
carried out using the hclust function in the statistical program-
ming language R and results were visualised using the corrplot 
function and hclust functions in R.
Results
Since little has been published thus far on the functional char-
acteristics of human mitoribosomes, we have defined a number 
of questions to explore patterns of behaviour. We have then 
compared the behaviour of the control human mitoribosome, 
which has a mt-tRNAVal component, against that of the cell line 
that has preferentially incorporated mt-tRNAPhe, as described 
above, in order to highlight the power of mitoribosomal profiling 
for detecting subtle alterations in ribosome function.
Analysis of the codon coverage within the protected 
mitoribosome footprints
The first question we addressed was whether the frequency with 
which each coding triplet is found within the mitoribosome 
protected footprints, directly reflected how often the triplet is 
found within the coding sequence of human mtDNA. One 
potentially confounding issue is the use of wobble base pairs. The 
human mitochondrial genome encodes only 22 tRNAs. This 
necessitates the use of wobble base pairings to permit the entire 
set of codon:anticodon interactions30. Since the use of a wobble 
represents an imperfect codon;anticodon it was possible that such 
mismatches could affect the dwell time of some aminoacylated 
mt-tRNA within the mitoribosome. If the dwell time is increased 
for inexact versus exact codon pairings, the mitoribosome 
residency would be increased and therefore the fractional abun-
dance for those codons within protected fragments would 
be higher than would be predicted from the calculated fraction 
of the same imperfect codons in the thirteen ORFs encoded 
in the mitochondrial genome.
The frequency of each codon present in the 13 open reading 
frames (ORFs) of human mtDNA was therefore plotted as the 
proportion (fractional abundance) found within the total reads 
from our protected RNA fragment libraries of mtDNA ORFs. 
Libraries derived from control osteosarcoma 143B.206 parental 
cells were generated from biological triplicate experiments 
(Figure 1A; Control, C; three biological repeats in cyan; mtDNA 
in red) and showed good reproducibility of data (Figure S1). 
The fractional abundance largely follows the frequency of the 
coding sequence with a number of exceptions where there is 
a statistically significant difference (marked by a blue cross 
below the codon). These differences do not occur for any set of 
codons representing a specific amino acid, nor are they restricted 
to wobble bases (designated in black text), suggesting that 
imperfect base pairing is not an impediment to translational 
efficiency (Figure 1A, perfect codon:anticodon pairs labelled in 
red text). For example, we find no evidence that the fractional 
abundance of either GAA or GAG (glutamic acid) codons in our 
protected RNA fragments differ significantly from their abun-
dance within the sequence of the mtDNA-encoded open reading 
frames despite GAA generating a perfect codon:anticodon pair, 
and GAG requiring a wobble. The aspartic acid GAC codon 
generates a perfect codon:anticodon pair whilst the GAU codon 
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Figure  1.  Mitochondrial  codon  usage  in  control  and  mutant  mitoribosome.  Mitoribosome footprints were analysed for codon 
coverage and their abundance compared to codon usage in the human mitochondrial genome. The frequency with which each of the 64 
codons is present in the open reading frames of human mtDNA was calculated (mtDNA). This was then compared to the proportion of 
which each codon was found in the total of all protected RNA fragments represented in the libraries generated from the three control cell 
lines (C1, 2, 3) (A). The data presented is FDR corrected, to generate a list of corrected q-values (where q < 0.05 is regarded as significant 
and marked by a blue cross beneath the codon). The boxed areas represent regions described in main text. B. The same analysis of 
mitoribosome coverage of each codon was performed comparing the control (C1-3; n=3) with the mutant cell line (M1- 3; n=3), which 
had substituted mt-tRNAVal with the mt-tRNAPhe. C. The mitoribosome distribution across MTCO2 for 3 different cell lines was plotted 
as a proportion of the footprints found over all the mt-ORFs in the library (fractional abundance). 143B.206 – blue, 143B cybrid – red, 
HEK293 – green.
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does not. In contrast, this canonically matched pairing displays 
significantly higher mitoribosome residency than the fractional 
abundance in the ORF sequences. Further, in human mitochon-
dria UGA is a codon that has been recoded from a canonical 
stop to be recognised by mt-tRNATrp and although the codon:
anticodon pair is a perfect match, the mitoribosome residency is 
significantly greater than expected when compared to the frac-
tional abundance in the mtDNA sequence. This is in con-
trast to the alternative tryptophan UGG codon that forms 
an imperfect pair, but where we found no difference to the 
fractional abundance predicted by the mtDNA ORFs.
Our previous analysis of a cell line harbouring a mutation in 
mt-tRNAVal identified a reduction in the steady state levels of 
mt-tRNAVal and that the presence of this destabilising mutation 
results in the substitution of mt-tRNAPhe into the large mitoribos-
omal subunit27,28. Although one might predict that this indicates 
an interchangeable arrangement that should not affect function, 
metabolic labelling of this cell line suggested that intramitochon-
drial protein synthesis was subtly impaired. The assumption at 
the time was that this was due to the reduced availability of charged 
mt-tRNAVal28. Further, since this cell line has integrated a fraction 
of the mt-tRNAPhe into the mitoribosome, there was a decreased 
proportion available for incorporation into elongating peptides. 
One hypothesis would be that mitoribosomes would pause over 
phenylalanine codons as there would be an extended time before 
pairing with an appropriately charged mt-tRNAPhe could occur. 
This premise would predict a greater relative abundance of 
phenylalanine codons in the resultant library of protected RNA 
fragments. We, therefore, aimed to identify whether the substitu-
tion of the structural mt-tRNA in the mitoribosome caused any 
pausing over the codons encoding either of these amino acids. 
Profiling data were collected from three biological repeats of the 
control (C; containing mt-tRNAVal) and mutant (Mut; contain-
ing mt-tRNAPhe) cell lines (Figure 1B). Surprisingly, no statisti-
cally significant differences in mitoribosome accumulation were 
identified over any of the codons. Most relevant, this was also 
true for all of the Val or Phe coding triplets, where there was no 
evidence of mitoribosome accumulation despite the lowered 
steady state levels of mt-tRNAVal, and the depletion of available 
charged mt-tRNAPhe due to its incorporation into the large 
subunits. This suggested that availability of each of these mt-
tRNAs was not limiting peptide elongation during the translation 
process.
Although this provides insight into codon usage it does not 
address the coverage or representation on individual transcripts, 
which requires the data to be interrogated in a different 
way.
How are the mitoribosomes distributed within open reading 
frames?
Data from Agami and colleagues described two sizes of mitori-
bosomal footprints with similar distribution across the tran-
scripts analysed. They hypothesised that this reflected the altered 
susceptibility of mt-mRNAs to RNases, due to different con-
formations adopted by the mitoribosome during translation 
elongation22. Our data was consistent with footprint sizes span-
ning 24 to 37 nucleotides. By plotting the distribution of these 
mitoribosomal footprints as a proportion of the total that are found 
across all the individual ORFs, the pattern of mitoribosome 
accumulation across the transcript can be easily viewed, as 
typified by the profile on MTCO2 (Figure 1C, and MTCO1 in 
Figure S1C). A similar trend but not identical trace was 
observed when different cell lines were analysed, including 143B 
osteosarcoma, transmitochondrial cybrid and HEK293 cell lines. 
Subsequent interrogation of the codons in the footprint, as well 
as the sequences flanking it may provide an explanation for any 
observed accumulation.
Previous in vitro studies by Spremulli and colleagues investi-
gated the interaction of the 55S monosome and the 28S mt-SSU 
with RNA templates that had AUG start codons with differing 
numbers of nucleotides upstream31. They were able to show that 
the mitoribosome binds the mt-mRNAs with a strong preference 
for start codons at the very 5’-terminus. Although eight of the 
human mt-mRNA species have the initiating codon in this 
position, this lack of untranslated regions (UTRs) is not universal. 
In fact, only 4 of the 13 open reading frames lack both associ-
ated 5’ and 3’ UTRs. Two transcription units are bicistronic with 
overlapping reading frames. One of these units, RNA14, encodes 
two components of the F
o
F1 ATP synthase, complex V of the 
OXPHOS system. The distal MTATP6 element is out of frame 
with the ORF for ATP8 and essentially acts as a 3’UTR for the 
upstream element. This arrangement also means that the 
5’ proximal MTATP8 coding sequence acts as the 5’UTR 
for MTATP6. A similar overlapping arrangement is found in 
RNA7 that encodes 2 subunits of complex 1, ND4 and ND4L. 
Three ORFs have leaders of 3 nucleotides or fewer32, one of which 
is MTCO1 with 3 nucleotides ahead of the start codon. The first 
151 nucleotides of this transcript was used as a template by Spre-
mulli and colleagues. Their analyses showed that the addition 
of even a single nucleotide ahead of the start codon for MTCO1 
reduced binding, and 3 nucleotides decreased formation of an 
initiation complex by more than 40%31. We, therefore, aimed to 
identify if the absence or presence of nucleotides preceding 
the initiating codon affected the mitoribosome residency over the 
initiation site in these transcripts in mitoribosome profiles from 
live cells. Further, since human mitochondria use AUA and AUU 
in addition to AUG as start codons, we also analysed whether 
the mitoribosome residency was affected by the non-canonical 
start codons. Interestingly, all the unconventional start codons are 
found in transcripts that have no 5’ UTRs, so that the first 
5’ nucleotide in the transcript corresponds to the first A residue 
of the initiation codon.
First, we found a substantial number of protected fragments 
that contained a 5’ residue corresponding to the initiation codon 
at, or very near to, the 5’ terminus of mature transcripts (e.g. 
Figure 1C, Figure S1). This was a surprise as these fragments 
ranged from 24–37 nucleotides and few were sufficiently small 
(15-17nt) to have mapped their initiation codon at the P site of 
the mitoribosome. Attempts to enrich other libraries for shorter 
protected species were unable to identify significant numbers 
of such short fragments that protected the initiation codon. We 
are not currently in position to interpret this data, but it is intrigu-
ing to speculate that it may indicate that protected fragments 
from preinitiation complexes are rare. We, therefore, analysed the 
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population of footprints that covered the 5’ terminal nucleotide of 
the transcript, or that initiated within 5 nucleotides downstream 
of the start codon. From within this population, all protected 
sequences that started with the same initial 5’ nucleotide were 
grouped together. These groups were aligned against their 
nucleotide position in the reference mtDNA sequence (Figure 2A, 
x axis). The relative abundance (y axis) of each of these 
groups (protected fragments with the same 5’ start site) is rep-
resented by the depth of each footprint block and is calculated 
as a proportion of footprints within that population of pro-
tected species found at the 5’ terminus. Two of the open reading 
frames that lack 5’ UTRs are MTCO2 and MTND4L (Figure 2A). 
In each case AUG is the initiating codon. Protected sequences 
in the former, indicate that 39% include the 5’ AUG (bottom 
block) after which the mitoribosome footprints shift into the 
open reading frame with a smaller proportional abundance at 
each site. This differs from the pattern seen for MTND4L, where 
only 5.4% of protected sequences cover the AUG start codon. 
The mitoribosome coverage at the 5’ terminus for MTND2 was 
also low at 2.8% despite this transcript initiating translation from 
the unconventional AUU. MTND3 also uses a recoded start 
codon, in this case AUA, but here 22.8% of the footprints cover 
the 5’ terminus, with a more equal distribution in each position 
as the mitoribosome moves into the open reading frame. This 
pattern more closely resembled that seen in MTCO1, which uses 
the conventional AUG start codon.
These data suggested that the unconventional start codons do not 
have a strong impact on mitoribosome occupancy under control 
conditions, but do they alter the interactions with a mitoribos-
ome that had integrated mt-tRNAPhe instead of mt-tRNAVal as 
the structural component of the mt-LSU? For the MTCO2 
transcript, the substituted mitoribosome distribution was very 
similar to control. The pattern of MTND4L in control showed 
a small proportion of the footprints at the very 5’ terminus with 
the distribution of the remaining footprints commencing over the 
next 5 nucleotides. The distribution of footprints from the mutant 
mitoribosome differed as the vast majority of protected species 
commenced 3–4 nucleotides after the start codon (Figure 2B). 
Since both MTND4L and MTCO2 use a canonical AUG as a 
start codon, and only the pattern for MTND4L is altered in the 
substituted mitoribosome, the differences in the footprint distri-
bution are unlikely to be related to the ability of the substituted 
mitoribosome to recognise AUG. There were more modest 
differences in mitoribosome behaviour between the control and 
mutant over both the AUA codon of MTND3 and the AUU of 
MTND2. In each case the footprints from the mutant mitoribos-
ome were staggered over four positions compared to a slightly 
different relative abundance distributed across the five footprints 
in the control (Figure 2B).
Two of the transcripts with limited non-coding sequence at the 
5’ terminus are MTCO1 and MTATP8, with 3 or 1 nucleotides, 
respectively, upstream of the initiating codon. Inspection of the 
control mitoribosome footprints at the 5’-terminus of these two 
transcripts reveals a distribution that is in stark contrast to those 
seen on the four transcripts described above that lack non-coding 
sequence at the 5’ terminus. Here, the footprints on MTCO1 
and ATP8 showed a similar distribution with the majority of 
protected sequences, 86% and 62% respectively, covering the 
non-coding nucleotides (Figure 2C). This difference in mitoribos-
ome behaviour is consistent with the in vitro observation that ini-
tiation is affected by nucleotides upstream of the start codon31. 
Do these minimal 5’UTRs have an even greater impact on the 
interaction with aberrant mitoribosomes containing mt-tRNAPhe? 
For MTCO1 the majority, albeit reduced (64% cf control 86%) 
of the footprints were still found to be covering the non-coding 
nucleotides after which the mitoribosome footprints moved 
downstream in a more incremental fashion than seen in the control 
(Figure 2 panels C and D). The redistribution of the mutant 
mitoribosome footprints on the transcript encoding ATP8 
was more distinct. Whether it was the presence of a single 
nucleotide 5’ proximal to the initiating AUA or the use of an 
unconventional start codon, the consequence was a redistribu-
tion of the mutant mitoribosome footprints. Whilst in the con-
trol the majority (62%) of footprints were positioned over the 
nucleotide preceding AUA, this diminished to 18% with the remain-
der of footprints being more evenly distributed across largely the 
same positions as found in the control (Figure 2 panels C and D).
The MTATP6 initiation codon is embedded within the bicistronic 
RNA14, such that the upstream out-of-frame ATP8 coding region 
acts as a 5’UTR. The start codon for translation of ATP6 is a 
canonical AUG, however, due to its internal position, the mecha-
nism by which the mitoribosome recognises this initiation site 
remains unclear. Since there are 162 nucleotides preceding 
the start site, this region may act as an internal ribosomal entry 
site (IRES) to recruit mitoribosomes. Examining the pattern of 
mitoribosome residency reveals that the control mitoribosome 
generates distinct footprints centred over the ATP6 initiation site 
(Figure 2E, upper panel). Immediately downstream there is a 
second footprint with a lower relative abundance of protected 
fragments that spans the stop codon for ATP8, which is displaced 
by 40 nucleotides from the ATP6 initiation site. In contrast, the 
substituted mitoribosome containing the mt-tRNAPhe recognises 
neither the internal start codon nor the stop codon with the same 
precision as the control (Figure 2E, mutant lower panel). For 
RNA7, the other bicistronic RNA unit, the overlap of coding 
sequence is limited to a single nucleotide intervening between 
the AUG start codon of MTND4 and the UAA stop of MTND4L, 
compared to 40 nucleotides separating the start and stop codons 
in RNA14. Again, the mechanism of mitoribosome recruitment 
to this site is undefined and this region may also act as an IRES. 
The overlap, however, is restricted to so few nucleotides that 
a -1 frameshift, which human mitoribosome have been shown 
to perform33, would position the AUG in the P-site to facilitate 
initiation. Analysis of this region showed that control cells 
displayed a distinct mitoribosome accumulation upstream of 
the sequence spanning the AUGCUAA overlap, in a region pre-
dicted to be an open loop, followed by a lesser accumulation 
over the stop/start transition predicted to fall within a short stem 
(Figure 2F, upper panel, Figure S2). The distribution of the 
substituted mitoribosome differs from this, with an increased 
residency slightly further downstream and a change in the propor-
tion of protected footprints just ahead of and over the stop/start 
transition compared to control. This profile displays an increase 
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Figure 2. Mitoribosomal footprint distribution at the 5’ terminus of mt-transcripts. Species that protected the 5’ terminal nucleotide of 
the transcript, or that mapped within 5 nucleotides downstream of the initiator codon were analysed as a pool and those that initiated with the 
same initial 5’ nucleotide were grouped together. The first 20 nucleotides of each group is plotted against the mtDNA reference sequence 
(x-axis) and the relative abundance is represented by the depth of each footprint block (y axis) calculated as a proportion of the population 
of protected species found at the 5’ terminus). Four transcripts that have start codons at the very 5’ terminus were analysed and the 
footprint position, length and relative abundance compared between control (A) and substituted mitoribosomes (B, Mutant). Mitoribosomal 
footprints on transcripts MTCO1 and MTATP8 with 3 or 1 nucleotides respectively that precede the start codon were mapped as 
above, for the control (C) and substituted mitoribosomes (D, Mutant). Panel (E) shows the raw IGV data of the mitoribosome footprints 
from the region of the bicistronic transcript, RNA14, where the reading frames of the MTATP8 and MTATP6 genes overlap. The control data 
is above and mutant data below. The nucleotide positions from the mtDNA reference sequence are in between with the two translation 
frames. The upper amino acid sequence relates to ATP8 with the termination site indicated by X. The lower sequence corresponds 
to the downstream ATP6 with the initiating methionine (M) shown in bold. Panel (F) depicts the overlap of MTND4L/MTND4 in RNA7 
a similar way.
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in the relative abundance of mitoribosomes where the open 
reading frames overlap (Figure 2F, lower panel). The substituted 
mitoribosome behaviour at stop sites was not always altered, 
even when the termination codon was followed by a short non- 
coding stretch of nucleotides, as the traces around the stop codon 
of MTCO2 were almost identical (Figure S3). This change in 
profile, together with that seen for RNA14 suggests that the 
substituted mitoribosome has more difficulty acting at these 
transition sites, and that despite the use of a conventional AUG 
start codon, the initiation at putative internal entry sites appears 
to be disrupted.
Our data indicate that there is no facile relationship between 
position or sequence of initiation codon and the relative occu-
pancy of the mitoribosome at either the 5’ termini, or embedded 
start sites of these transcripts. RNA structures downstream of the 
footprint, however, might be expected to contribute to the proces-
sivity of the mitoribosome. Prediction programmes for RNA 
structures have been refined significantly but without experimen-
tal confirmation they remain provisional. To overcome this, the 
Spremulli group used SHAPE chemistry to analyse the interac-
tion of the mitoribosome with the mt-mRNAs34. This allowed 
them to determine the structures and respective stability of the 
5’-termini of various human mt-transcripts, which were different 
to those predicted by RNAstructure35. The substituted mitoribos-
ome behaved differently when initiating translation on a number 
of ORFs including all four encoded on the two bicistronic 
elements (RNA7 and RNA14). The differences in behaviour were 
seen both at the 5’-termini as well as at the internal start sites 
of both downstream ORFs. SHAPE chemistry determined that 
the 5’-termini of both MTND4L and MTATP8 have the ability to 
generate single stem loops. In the case of MTND4L the initiating 
AUG is found as the first nucleotides in the paired stem, whilst 
for MTATP8 this structure is 1 nucleotide downstream of the 
start codon. Although the footprint profiles over or close to the 
start codon might suggest that the recognition and effective 
interaction with the mutant translation machinery is compromised, 
neither of these structures is predicted to be more stable than a 
single G-C base pair34 and so is unlikely to impede progress of 
the mitoribosome. The internal initiation codons in both RNA14 
and RNA7 were determined to be highly unstructured regions34. 
Hence, RNA structure was unlikely to be the cause of the 
difference in the recognition of the signals and behaviour of the 
mutant mitoribosome in the regions encompassing the start/stop 
transitions. The MTCO1 transcript also showed a difference in 
behaviour at the initiation codon in the control and mutant cell 
lines. In addition to the effect of nucleotides preceding the start 
codon, SHAPE chemistry determined the AUG start to be in a 
conformationally flexible region with the first reasonably stable 
secondary structure to be 39 nucleotides downstream34. It is 
possible that the first stem loop that occurs just ahead of the 
mitoribosome after it has initiated translation, selectively affects 
the progress of the mt-tRNAPhe containing mitoribosome 
compared to the control.
It has been proposed that in addition to the influence of the 
mRNA sequence or structure, the characteristics of the translation 
product itself may influence the local interactions and alter 
the transit time of the nascent peptide through the ribosomal 
exit tunnel, thus restricting the movement of a ribosome on its 
template mRNA25. The human mitoribosome appears to 
have adapted the exit tunnel to accommodate for the highly 
hydrophobic nature of the nascent peptides. CryoEM charac-
terisation of the mt-LSU shows particular involvement of uL22 
in facilitating hydrophobic interactions that could enhance 
interactions of the translation product with the tunnel wall25. It also 
indicates that the stretch of newly synthesised protein closest to 
the exit site can have already adopted a helical formation25. Any 
condensation of the structure would also make it difficult to 
determine the overall length of each translation product within the 
tunnel once the mitoribosome had progressed along the transcript. 
To determine whether the characteristics of the initial peptide 
could explain the mitoribosome profiles we inspected the hydro-
pathicity predictions of the initial 10 amino acids of transcripts 
described above. Using ExPASy programmes where a positive 
score indicates hydrophobicity36,37, these products were predicted 
to generate hydrophobic peptides. The most hydrophobic was 
the translation product of MTND4 with a hydrophobicity score 
of 1.84, followed by MTND3 (1.80), then MTCO2 and MTND2 
both with a score 0.47. Since the substitution of mt-tRNAVal for 
mt-tRNAPhe may have structural implications for the mitori-
bosome, which we discuss later, we wished to identify if the 
difference in behaviour we observed at early stages of transla-
tion correlated with the hydrophobicity prediction. Of these eight 
transcripts analysed, including both elements of the two bicis-
tronic elements, six showed footprints that differed from the 
control. The altered footprint distribution did not, however, 
reflect the hydrophobicity of the initial peptides, as the most dis-
tinct differences in mitoribosome behaviour were seen on the 
transcripts for MTND4L and MTATP8 with widely different 
hydropathicity predictions of 1.59 and -0.26 respectively. The 
differences in this characteristic do not easily explain the mitori-
bosome residency patterns seen around this initiation sites of 
these transcripts. Since the hydrophobicity did not appear to exert 
an effect, we looked at the structural prediction for the initial 
peptide sequence (Table S1). Of the analysed transcripts only the 
translation product of MTND2 showed any helical propensity, 
suggesting that the formation of a structure within the exit 
tunnel was not a major factor in mitoribosome residency during 
the initiation stages for these transcripts. We could not, therefore, 
attribute any changes in relative translational efficiency of the 
mt-tRNAPhe containing mitoribosome to either the hydrophobic 
character or the structure of the initial peptide.
Discussion
Our analyses reveal that a human mitoribosome that substitutes 
mt-tRNAPhe into the large subunit as a structural component in 
preference to a mutant mt-tRNAVal, displays subtle differences 
in its interaction with mt-mRNA templates when compared to 
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the control. We have examined a number of elements that might 
have been predicted to contribute to this change in behaviour 
but have not found any convincing evidence to support a simple 
explanation.
Unfortunately, there is currently insufficient detailed structural 
data on how either the human mt-tRNAVal or mt-tRNAPhe are 
held within the mt-LSU to be able to predict precisely how inser-
tion of the latter might affect the conformation of the mt-LSU 
in the context of the monosome, to drive these differences in 
behaviour. Nor do we currently know the extent to which either 
mt-tRNAPhe and mt-tRNAVal are modified when they are inte-
grated into the mt-LSU. Thus, we cannot determine whether 
differences in post-transcriptional modifications change the 
charge distribution or alter the conformation of the monosome, 
particularly with respect to the central protuberance (CP). 
This is important, as despite the exchange of a 5S rRNA for 
a mitochondrially encoded tRNA the central protuberance has 
retained two functions in common with its bacterial 70S coun-
terpart. Unlike the 70S, these functions involve mitochondrial 
specific proteins that facilitate the i) interaction of the mt-LSU 
with the small subunit and ii) interaction with the mt-tRNAs. 
Although the cryoEM data cannot distinguish the precise 
elements that are involved in mediating these functions it can 
assign a mitochondrial specific mass at the base of the central 
protuberance, which crucially is coordinated by mt-tRNAVal25. 
These proteins are clustered in a region that is predicted 
to undergo structural rearrangement during translation38 and the 
flexibility to alter the conformation is believed to be expedited 
by mt-tRNAVal25. Thus, the substitution of mt-tRNAVal for 
mt-tRNAPhe may have functional consequences on the central 
protuberance by affecting the potential of the mt-LSU to change 
in flexibility/conformation and may in part be the cause of 
the altered behaviour of the substituted mitoribosome.
We hope at some stage in the future it will be possible to generate 
cryoEM structures from the mt-tRNAPhe containing mitori-
bosome to gain insight into how a structural change may have 
contributed to this alteration in translation. Such structures may 
reveal changes in conformation following mt-LSU incorpora-
tion of the mt-tRNAPhe that indicate whether it is the fidelity of 
translation that is reduced, causing the production of aberrant 
polypeptides that are more rapidly degraded. This would explain 
the lowered steady state levels of mtDNA encoded proteins 
previously observed in cell lines harbouring the mt-tRNAVal 
mutation28.
A mitoribosome profiling approach could be also used to reveal 
the pathological mechanisms underlying many other mutations 
that affect mitochondrial gene expression at a molecular level. 
In addition to the example we have presented, mitoribosomes 
have been identified as accumulating over the different codons 
encoding tryptophan as a consequence of a mutation in the 
mitochondrially encoded tRNATryp22. It is probable that muta-
tions in other mtDNA encoded tRNAs or in the enzymes respon-
sible for their maturation and modification may also affect codon 
usage. Further, it would be interesting to identify whether any 
changes in codon usage from such mutations can be correlated 
to the frequency of a particular codon in the genes of different 
OXPHOS complexes, thereby explaining the more severe 
pathological phenotype in one complex over another.
Mitoribosome pausing may also reflect a physiological mecha-
nism that coordinates co-translation of interacting polypeptides 
from the same OXPHOS complex. Analogous to the way in 
which signal recognition particles bind nascent peptides emerg-
ing from cytosolic ribosomes to delay translation, features within 
the mtDNA encoded transcripts may arrest mitoribosomes until 
the protruding domain of the nascent peptide docks with its 
cognate partners. This mechanism could facilitate co-translation 
both of mitochondrially encoded proteins as well as coordinating 
intra-mitochondrial translation with the import, or indeed 
co-translational translocation, of nuclear encoded components of 
OXPHOS complexes. There are an increasing number of pro-
teins know to be involved in mitochondrial gene expression and 
complex assembly. Examining the protected RNA profiles from 
cell lines with mutations in these proteins, as well as in cells 
depleted of relevant chaperones, insertases or complex assembly 
factors could help define the level of control that is exerted by 
the mitoribosome on assembly of the OXPHOS complexes. 
CRISPR/Cas9 or siRNA technology could also be combined 
with profiling to target depletion of candidate proteins of known 
mitochondrial localisation but of unknown function to elucidate 
the putative roles in translation that these proteins perform, by 
comparing the depleted profiles against those of controls.
There is further interrogation of data derived from mitoribosome 
profiling that remains to be done. This will yield both a better 
understanding of the fundamental mechanisms governing mitori-
bosome behaviour in mammals, and will also give a molecular 
insight into the mechanisms causing the specific pathogenic 
effects associated with different mitochondrial diseases.
Abbreviations: Mitochondrial, mt; transfer RNA, tRNA; 
mitoribosomal large subunit, mt-LSU; mitoribosomal small 
subunit, mt-SSU.
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Supplementary material
Figure S1. Unsupervised hierarchical clustering of fractional abundance profiles and mitoribosomal profile on MTCO1 
A. Dendrogram showing a hierarchy of similarity between profiles of the fractional abundance of t-RNA footprints across codons for 
three replicate wild-type control cell lines (C1, 2, 3), three replicate experimental mutant cybrid lines (M 1, 2, 3) and general fractional 
abundance of codons in the coding regions of mtDNA (mtDNA). The similarity between two profiles, i and j is defined as 1.0 - Cij 
where Cij is the Pearson’s correlation coefficient between profile i and profile j. B. Matrix showing Cij for all combinations of i and j. 
Profiles and correlations enclosed by black lines highlight how unsupervised hierarchical clustering assigns profiles into groups when 
told to expect three groups. C. The mitoribosome distribution across MTCO1 for 3 repeat of the same cell line was plotted as a proportion 
of the footprints found over all the mt-ORFs in the library (fractional abundance).
Click here to access the data.
Figure S2. Predicted structure of RNA7
An RNAfold prediction of RNA7 is presented with a box indicating the position of the overlap of the two sequences encoding ND4L and 
ND4.
Click here to access the data.
Figure S3. Distribution of mitoribosomal footprints surrounding the 3’ terminus of MTCO2
The primary IGV data presents the mitoribosome footprints from the region covering the stop codon and the short 3’UTR of the MTCO2 
transcript prior to the poly(A) tail. The control data is above and mutant data below. The nucleotide positions from the mtDNA reference 
sequence are in between with the termination site indicated by X.
Click here to access the data.
Table S1. Characteristics of the first 36 amino acids in selected open reading frames of human mtDNA.
Click here to access the data.
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